The top U.S. theater chain [AMC],
controlled by China’s Dalian Wanda Group, is currently the focus of an
Prospects for the
finalization of AMC Theatres’ $1.1 billion acquisition of Carmike Theatres
grewcloudier Tuesday, after shareholders in the targeted chain said they
would oppose the deal.
Carmike shares edged up
and AMC’s were down after Mittleman Bros., the leading Carmike shareholder with
7.1 percent of its stock, said it would fight the deal.
At the same time,
analysts’ increasing focus on the intense scrutiny the deal will face from the
Justice Department — which is currently investigating AMC over alleged
antitrust violations — is certain to create moredownward pressure on the
The ramifications of the
deal, or its unraveling, are global.